These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2082485)

  • 1. Dipyridamole combined with anticoagulant in prevention of early postoperative thromboembolism after cardiac valve replacement.
    Kawazoe K; Fujita T; Manabe H
    Thromb Res Suppl; 1990; 12():27-33. PubMed ID: 2082485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.
    Chesebro JH; Fuster V; Elveback LR; McGoon DC; Pluth JR; Puga FJ; Wallace RB; Danielson GK; Orszulak TA; Piehler JM; Schaff HV
    Am J Cardiol; 1983 May; 51(9):1537-41. PubMed ID: 6342354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
    Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].
    Ciavarella N; Antoncecchi S; D'Elia N
    Cardiologia; 1985 Apr; 30(4):301-7. PubMed ID: 3914360
    [No Abstract]   [Full Text] [Related]  

  • 5. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
    Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
    J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
    Mok CK; Boey J; Wang R; Chan TK; Cheung KL; Lee PK; Chow J; Ng RP; Tse TF
    Circulation; 1985 Nov; 72(5):1059-63. PubMed ID: 3899404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
    Sullivan JM; Harken DE; Gorlin R
    N Engl J Med; 1971 Jun; 284(25):1391-4. PubMed ID: 4931099
    [No Abstract]   [Full Text] [Related]  

  • 8. Standard versus low-level anticoagulation combined to low-dose dipyridamole after mitral valve replacement.
    Hassouna A; Allam H; Awad A; Hassaballah F
    Cardiovasc Surg; 2000 Oct; 8(6):491-8. PubMed ID: 10996106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation therapy in children with mechanical prosthetic cardiac valves.
    Bradley LM; Midgley FM; Watson DC; Getson PR; Scott LP
    Am J Cardiol; 1985 Sep; 56(8):533-5. PubMed ID: 4036839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulants and the Björk-Shiley prosthesis. Experience of 390 patients.
    Sutton MG; Miller GA; Oldershaw PJ; Paneth M
    Br Heart J; 1978 May; 40(5):558-62. PubMed ID: 656224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of prosthetic valve-related complications with very low level warfarin anticoagulation combined with dipyridamole after valve replacement using St. Jude Medical prostheses.
    Skudicky D; Essop MR; Wisenbaugh T; Skoularigis J; Essop AR; Dullabh A; Bedhesi S; Strugo V; Sareli P
    Am J Cardiol; 1994 Dec; 74(11):1137-41. PubMed ID: 7977074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.
    Sullivan JM; Harken DE; Gorlin R
    N Engl J Med; 1968 Sep; 279(11):576-80. PubMed ID: 5667468
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Persantine in preventing thromboembolism following valve replacement.
    Arrants JE; Hairston P
    Am Surg; 1972 Aug; 38(8):432-5. PubMed ID: 5045046
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulant therapy in children with prosthetic valves.
    Rao PS; Solymar L; Mardini MK; Fawzy ME; Guinn G
    Ann Thorac Surg; 1989 Apr; 47(4):589-92. PubMed ID: 2712632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithromboembolic treatment after cardiac valve replacement.
    Kudoh T
    Jpn Circ J; 1984 Oct; 48(10):1169-71. PubMed ID: 6492383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valve replacement.
    Stewart S; Cianciotta D; Alexson C; Manning J
    J Thorac Cardiovasc Surg; 1987 Apr; 93(4):551-4. PubMed ID: 3561002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy in children with left-sided mechanical prostheses.
    LeBlanc JG; Sett SS; Vince DJ
    Eur J Cardiothorac Surg; 1993; 7(4):211-5. PubMed ID: 8481259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet survival time following aortic valve replacement.
    Steele P; Weily H; Davies H; Ppppas G; Genton E
    Circulation; 1975 Feb; 51(2):358-62. PubMed ID: 1112016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.